The new funding will help the cluster build on initial milestones and to prepare for clinical applications, particularly in cancer.

Bionano Genomics, Inc. (Nasdaq: BNGO) today announced highlights from Day 3 of Bionano Symposium 2026, entitled OGM Making its Mark in Constitutional Genetic Disorders. Presentations highlighted how ...

The panel ensures compatibility with our previous autosomal Family Finder tests plus all the autosomal transfers we ...

BioVenic is dedicated to advancing the advancement of veterinary molecular diagnostics through its comprehensive ...

In India, rare diseases are not so rare. It is estimated that around 70 million Indians live with one of more than 7,000 rare diseases, many of which are genetic […] ...

Molecular diagnostics market size to reach USD 38.01 billion by 2034: Polaris Market Research: United States Thursday, February 19, 2026, 09:00 Hrs [IST] The molecular diagnostics ...

Increase in prevalence of genetic disorders, shift towards personalized medicine, and surge in demand for forensic DNA analysis are the major factors which drive the global genotyping market growth.

Background Monogenic disorders are a major cause of fetal structural anomalies. Most genetic diagnoses involve de novo, biallelic or X linked variants; however, inherited variants in autosomal ...

The growth of the genomics market is driven by the rising prevalence of genetic disorders and cancer, along with increasing awareness of early disease detection through genetic testing. WILMINGTON, ...